Source: Malaria Journal. Unidade: FM
Subjects: CUSTO ECONÔMICO, MALÁRIA (EPIDEMIOLOGIA;QUIMIOTERAPIA), SURTOS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MASSAD, Eduardo et al. Cost risk benefit analysis to support chemoprophylaxis policy for travellers to malaria endemic countries. Malaria Journal, v. 10, n. 130, 2011Tradução . . Disponível em: https://doi.org/10.1186/1475-2875-10-130. Acesso em: 22 ago. 2024.APA
Massad, E., Behrens, B. C., Coutinho, F. A. B., & Behrens, R. H. (2011). Cost risk benefit analysis to support chemoprophylaxis policy for travellers to malaria endemic countries. Malaria Journal, 10( 130). doi:10.1186/1475-2875-10-130NLM
Massad E, Behrens BC, Coutinho FAB, Behrens RH. Cost risk benefit analysis to support chemoprophylaxis policy for travellers to malaria endemic countries [Internet]. Malaria Journal. 2011 ; 10( 130):[citado 2024 ago. 22 ] Available from: https://doi.org/10.1186/1475-2875-10-130Vancouver
Massad E, Behrens BC, Coutinho FAB, Behrens RH. Cost risk benefit analysis to support chemoprophylaxis policy for travellers to malaria endemic countries [Internet]. Malaria Journal. 2011 ; 10( 130):[citado 2024 ago. 22 ] Available from: https://doi.org/10.1186/1475-2875-10-130